Baxter International (BAX) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Baxter International Inc. (BAX) insider buying and selling: none on the open market
43 Form 4 Table I transactions filed with the SEC by Baxter International Inc. insiders between 2025-09-04 and 2026-09-03 (15-month history): 0 open-market purchases and 0 sales, plus 43 transactions under other Form 4 codes, broken down one by one below. There are no open-market purchases or sales in this period: every transaction carries another code, broken down below.
Baxter International insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, no Baxter International insider filed an open-market purchase or sale (Form 4 codes P and S). They did file 39 transactions under other codes, broken down below.
Against its sector (Healthcare, 59 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. Baxter International has no sales, like 4 of the other 58, and 19 of the 59 have at least one purchase.
The 20 most important trades
With no open-market buys or sells, these are its transactions under other codes, largest first. The full history is in the tool above, already searched.
See all 43 BAX trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | 2026-09-03 | Hider Andrew P. | President and CEO | $1.4M | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2026 from the settlement of vested restricted stock units granted on September 2, 2025. F2 Total includes the automatic reinvestment of dividends. | SEC |
| 2026-03-06 | 2026-03-10 | Rasul Reazur | EVP, Group Pres, Healthcare | $224k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. | SEC |
| 2026-02-09 | 2026-02-11 | Grade Joel T. | EVP and CFO | $199k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. F3 Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan. | SEC |
| 2025-12-01 | 2025-12-03 | Grade Joel T. | EVP and CFO | $158k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 1, 2025 from the settlement of vested restricted stock units granted on December 1, 2023. F2 Total includes the automatic reinvestment of dividends. | SEC |
| 2026-03-06 | 2026-03-10 | Grade Joel T. | EVP and CFO | $144k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. | SEC |
| 2026-02-09 | 2026-02-11 | Rasul Reazur | EVP, Group Pres, Healthcare | $125k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. F3 Total includes the automatic reinvestment of dividends. | SEC |
| 2026-03-06 | 2026-03-10 | Rosenbloom David S. | EVP and General Counsel | $117k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. | SEC |
| 2026-02-09 | 2026-02-11 | Rosenbloom David S. | EVP and General Counsel | $114k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. F3 Total includes the automatic reinvestment of dividends. | SEC |
| 2025-09-02 | 2025-09-04 | Sonig Alok | EVP, Group President, Pharma | $77k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2025 from the settlement of vested restricted stock units granted on September 1, 2022 F2 Total includes the automatic reinvestment of dividends. | SEC |
| 2026-09-02 | 2026-09-03 | Foster Julie | President, Front Line Care | $54k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2026 from the settlement of vested restricted stock units granted on September 2, 2025. F2 Total includes the automatic reinvestment of dividends. | SEC |
| 2026-03-06 | 2026-03-10 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | $50k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. | SEC |
| 2025-09-02 | 2025-09-04 | Borzi James W | EVP, Chief Supply Chain Officer | $45k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2025 from the settlement of vested restricted stock units granted on September 1, 2023. F2 Total includes the automatic reinvestment of dividends. | SEC |
| 2026-03-02 | 2026-03-03 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | $36k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. | SEC |
| 2026-03-06 | 2026-03-10 | Zielinski Anita A | SVP, CAO and Controller | $34k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2025. | SEC |
| 2026-03-02 | 2026-03-03 | Rasul Reazur | EVP, Group Pres, Healthcare | $32k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. | SEC |
| 2026-03-02 | 2026-03-03 | Rosenbloom David S. | EVP and General Counsel | $26k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. | SEC |
| 2026-02-09 | 2026-02-11 | Soriano Maria Cecilia | Group Pres., ITT & Pharma. | $20k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. F3 Total includes the automatic reinvestment of dividends. | SEC |
| 2026-09-01 | 2026-09-03 | Teaff James | President, CCS | $19k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 1, 2026 from the settlement of vested restricted stock units granted on September 1, 2023. F2 Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan. | SEC |
| 2025-12-12 | 2025-12-16 | Mason Jeanne K | EVP, Chief HR Officer | $12k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares forfeited by the reporting person to cover the withholding of accelerated Federal Insurance Contributions Act (FICA) taxes for restricted stock unit awards previously granted under Baxter International Inc.'s Long-Term Incentive Plan. F2 Total includes the automatic reinvestment of dividends. | SEC |
| 2026-06-02 | 2026-06-03 | Teaff James | President, CCS | $6k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2026, from the settlement of vested restricted stock units granted on June 2, 2025. F2 Total includes shares held in the Baxter's Employee Stock Plan. | SEC |
The period balance: money in, money out
Between Sep 4, 2025 and Sep 3, 2026 there is no open-market activity in Baxter International Inc.: the 43 filed transactions all carry other codes, and they are the ones in the table below.
Only codes P and S count, where an insider puts in or takes out their own money. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| A | Grant or award | 22 | $0 |
| F | Tax withholding (shares surrendered for taxes) | 21 | $2.9M |
| Total | Everything filed in the period | 43 | $2.9M |
22 of the 43 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 21 distinct people or entities have filed Baxter International Inc. transactions: none bought on the open market and none sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Grade Joel T. | EVP and CFO | 6 | — | — | 2026-03-10 |
| Rosenbloom David S. | EVP and General Counsel | 5 | — | — | 2026-03-10 |
| Soriano Maria Cecilia | Group Pres., ITT & Pharma. | 5 | — | — | 2026-03-10 |
| Rasul Reazur | EVP, Group Pres, Healthcare | 4 | — | — | 2026-03-10 |
| Hider Andrew P. | President and CEO | 3 | — | — | 2026-09-03 |
| Zielinski Anita A | SVP, Interim CFO, CAO & Cntrlr | 3 | — | — | 2026-06-03 |
| Mcdonnell Michael R. | Director | 2 | — | — | 2026-05-07 |
| Teaff James | President, CCS | 2 | — | — | 2026-09-03 |
Shown here are the 8 who moved the most money, out of 21. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
Across the 15 months of history there is no open-market trade at all in Baxter International Inc., so no calendar is published: 15 rows of zeros would fake a pattern where there is no sample to read. Everything filed is listed, with its date, in the tables above.
Baxter International Inc. (BAX) analysis page →
Other Healthcare companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
Baxter International has no open-market purchase (code P) in the history, the most common case in the S&P 500: insiders are already paid in stock. The latest filing is from Sep 3, 2026, and a Form 4 arrives up to two business days after the trade.
20 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.